Literature DB >> 20683888

What is evidence?

Sharon-Lise T Normand1, Barbara J McNeil.   

Abstract

The assumption that comparative effectiveness research will provide timely, relevant evidence rests on changing the current framework for assembling evidence. In this commentary, we provide the background of how coverage decisions for new medical technologies are currently made in the United States. We focus on the statistical issues regarding how to use the ensemble of information for inferring comparative effectiveness. It is clear a paradigm shift in how clinical information is integrated in real-world settings to establish effectiveness is required. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh：

Year:  2010        PMID： 20683888      PMCID： PMC2917254          DOI： 10.1002/sim.3933

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


  9 in total

1.  The hazards of scoring the quality of clinical trials for meta-analysis.

Authors:  P Jüni; A Witschi; R Bloch; M Egger
Journal:  JAMA       Date:  1999-09-15       Impact factor: 56.272

2.  Toward evidence-based medical statistics. 2: The Bayes factor.

Authors:  S N Goodman
Journal:  Ann Intern Med       Date:  1999-06-15       Impact factor: 25.391

3.  On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions.

Authors:  S Greenland; K O'Rourke
Journal:  Biostatistics       Date:  2001-12       Impact factor: 5.899

4.  Network meta-analysis for indirect treatment comparisons.

Authors:  Thomas Lumley
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

5.  Medicare's national coverage decisions for technologies, 1999-2007.

Authors:  Peter J Neumann; Maki S Kamae; Jennifer A Palmer
Journal:  Health Aff (Millwood)       Date:  2008 Nov-Dec       Impact factor: 6.301

6.  A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting.

Authors:  S Shea; W DuMouchel; L Bahamonde
Journal:  J Am Med Inform Assoc       Date:  1996 Nov-Dec       Impact factor: 4.497

7.  Representation of elderly persons and women in published randomized trials of acute coronary syndromes.

Authors:  P Y Lee; K P Alexander; B G Hammill; S K Pasquali; E D Peterson
Journal:  JAMA       Date:  2001-08-08       Impact factor: 56.272

8.  Correlated bivariate continuous and binary outcomes: issues and applications.

Authors:  Armando Teixeira-Pinto; Sharon-Lise T Normand
Journal:  Stat Med       Date:  2009-06-15       Impact factor: 2.373

9.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272
  9 in total
  7 in total

1.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

2.  Improving efficiency and reducing costs: Design of an adaptive, seamless, and enriched pragmatic efficacy trial of an online asthma management program.

Authors:  Mei Lu; Dennis R Ownby; Edward Zoratti; Douglas Roblin; Dayna Johnson; Christine Cole Johnson; Christine L M Joseph
Journal:  Contemp Clin Trials       Date:  2014-03-06       Impact factor: 2.226

3.  Multiple outcomes and multiple sources of evidence: best statistical practices.

Authors:  Sharon-Lise T Normand
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-11-01

Review 4.  Computer disease simulation models: integrating evidence for health policy.

Authors:  Carolyn M Rutter; Amy B Knudsen; Pari V Pandharipande
Journal:  Acad Radiol       Date:  2011-03-23       Impact factor: 3.173

5.  Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study.

Authors:  Margrietha van der Linde; Nikki van Leeuwen; Frank Eijkenaar; Anita W Rijneveld; Rob Pieters; Henrike E Karim-Kos
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

Review 6.  Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.

Authors:  Katrina A B Goddard; William A Knaus; Evelyn Whitlock; Gary H Lyman; Heather Spencer Feigelson; Sheri D Schully; Scott Ramsey; Sean Tunis; Andrew N Freedman; Muin J Khoury; David L Veenstra
Journal:  Genet Med       Date:  2012-07       Impact factor: 8.822

7.  Adjusting for confounding by indication in observational studies: a case study in traumatic brain injury.

Authors:  Maryse C Cnossen; Thomas A van Essen; Iris E Ceyisakar; Suzanne Polinder; Teuntje M Andriessen; Joukje van der Naalt; Iain Haitsma; Janneke Horn; Gaby Franschman; Pieter E Vos; Wilco C Peul; David K Menon; Andrew Ir Maas; Ewout W Steyerberg; Hester F Lingsma
Journal:  Clin Epidemiol       Date:  2018-07-18       Impact factor: 4.790
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.